FAQs on the Use of BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
ExpressPointsNext-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
BCMA-Targeted Bispecific T-Cell Engagers and Bispecific Monoclonal Antibodies in R/R MM

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast Pearls: Optimizing Therapy for Relapsed/Refractory Multiple Myeloma

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
How We Select Treatment in R/R Myeloma: A Conversation With 3 Experts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How I Am Managing My Patients With Myeloma During the COVID-19 Pandemic

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--